Literature DB >> 21969178

Exosome/microvesicle-mediated epigenetic reprogramming of cells.

Giovanni Camussi, Maria-Chiara Deregibus, Stefania Bruno, Cristina Grange, Valentina Fonsato, Ciro Tetta.   

Abstract

Microvesicles (MVs) are released by different cell types and may remain in the extracellular space in proximity of the cell of origin or may enter the biological fluids. MVs released by tumor cells are detectable in patients with cancer and their number in the circulation correlates with poor prognosis. Recent studies demonstrated that MVs may act as mediator of cell-to-cell communication thus ensuring short- and long-range exchange of information. Due to their pleyotropic effects, MVs may play a role in the prothrombotic state associated with cancer as well as in cancer development and progression. It has been recently shown that MVs may induce epigenetic changes in target cells by transferring genetic information. This finding suggests that tumor and stromal cells may talk each other via MVs to establish a favorable tumor niche and to promote tumor growth, invasiveness and progression. Moreover, MVs contain genetic material under the form of mRNA and microRNA, that may allow an easy screening for cancer genetic markers and offer new diagnostic and prognostic information. This review presents an overview of the many biological actions of MVs and of the potential role of MV-mediated exchange of genetic information among cells in tumor biology.

Entities:  

Year:  2010        PMID: 21969178      PMCID: PMC3180104     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  101 in total

Review 1.  Flow cytometric analysis of circulating microparticles in plasma.

Authors:  Aaron F Orozco; Dorothy E Lewis
Journal:  Cytometry A       Date:  2010-06       Impact factor: 4.355

Review 2.  Exosomes: proteomic insights and diagnostic potential.

Authors:  Richard J Simpson; Justin We Lim; Robert L Moritz; Suresh Mathivanan
Journal:  Expert Rev Proteomics       Date:  2009-06       Impact factor: 3.940

Review 3.  Dendritic cell-derived exosomes for cancer immunotherapy: what's next?

Authors:  Sophie Viaud; Clotilde Théry; Stéphanie Ploix; Thomas Tursz; Valérie Lapierre; Olivier Lantz; Laurence Zitvogel; Nathalie Chaput
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

6.  Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells.

Authors:  Thomas J O'Neill; Brian R Wamhoff; Gary K Owens; Thomas C Skalak
Journal:  Circ Res       Date:  2005-10-06       Impact factor: 17.367

7.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.

Authors:  Monika Baj-Krzyworzeka; Rafał Szatanek; Kazimierz Weglarczyk; Jarosław Baran; Barbara Urbanowicz; Piotr Brański; Mariusz Z Ratajczak; Marek Zembala
Journal:  Cancer Immunol Immunother       Date:  2005-11-09       Impact factor: 6.968

8.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

Authors:  Jeong Whun Kim; Eva Wieckowski; Douglas D Taylor; Torsten E Reichert; Simon Watkins; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

9.  The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.

Authors:  Chloe Milsom; Joanne Yu; Linda May; Brian Meehan; Nathalie Magnus; Khalid Al-Nedawi; Jim Luyendyk; Jefferey Weitz; Petr Klement; George Broze; Nigel Mackman; Janusz Rak
Journal:  Thromb Res       Date:  2007       Impact factor: 3.944

10.  High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.

Authors:  Mariantonia Logozzi; Angelo De Milito; Luana Lugini; Martina Borghi; Luana Calabrò; Massimo Spada; Maurizio Perdicchio; Maria Lucia Marino; Cristina Federici; Elisabetta Iessi; Daria Brambilla; Giulietta Venturi; Francesco Lozupone; Mario Santinami; Veronica Huber; Michele Maio; Licia Rivoltini; Stefano Fais
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more
  181 in total

Review 1.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 2.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

3.  miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.

Authors:  Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Shirley Phillips; Vivek Kaimal; Ying Mao; Wei Hua; Isaac Yang; Chia-Chun Fu; John Nolan; Ichiro Nakano; Yuanfan Yang; Martin Beaulieu; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2015-04-23       Impact factor: 4.130

Review 4.  The role of microvesicles in tissue repair.

Authors:  Ciro Tetta; Stefania Bruno; Valentina Fonsato; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

Review 5.  Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.

Authors:  Katarzyna Nazimek; Krzysztof Bryniarski; Philip W Askenase
Journal:  Int Arch Allergy Immunol       Date:  2016-11-08       Impact factor: 2.749

Review 6.  Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Authors:  Ji-Hye Jung; Xuebin Fu; Phillip C Yang
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

7.  Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.

Authors:  A E Berezin; A A Kremzer; T A Samura; T A Berezina; P Kruzliak
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

8.  Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery.

Authors:  Jieke Cui; Qing Li; Mei Luo; Zhaodong Zhong; Shu Zhou; Lin Jiang; Na Shen; Zhe Geng; Hui Cheng; Li Meng; Shujuan Yi; Hui Sun; Feifei Wu; Zunmin Zhu; Ping Zou; Yong You; An-Yuan Guo; Xiaojian Zhu
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

9.  Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Authors:  Marta Szajnik; Magdalena Derbis; Michal Lach; Paulina Patalas; Marcin Michalak; Hanna Drzewiecka; Dariusz Szpurek; Andrzej Nowakowski; Marek Spaczynski; Włodzimierz Baranowski; Theresa L Whiteside
Journal:  Gynecol Obstet (Sunnyvale)       Date:  2013-04-29

Review 10.  Microfluidic transport in microdevices for rare cell capture.

Authors:  James P Smith; Alexander C Barbati; Steven M Santana; Jason P Gleghorn; Brian J Kirby
Journal:  Electrophoresis       Date:  2012-10-12       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.